(Sharecast News) - Novartis said on Monday that it has agreed to buy Myricx, a privately held UK biotechnology company firm, for up to $1.5bn.
The Swiss drug maker said the deal would strengthen its oncology pipeline and advance next-generation targeted drug conjugates with novel payload mechanisms.

Headquartered in London...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE